Amra measures $9m series A

Linköping University spinout Amra is working on technology to better understand obesity and metabolic risk and has received cash from investors including Stiftelsen Industrifonden.

Amra, a personalised medicine spinout of Linköping University, raised $9m in a series A round on Tuesday from investors including Stiftelsen Industrifonden, the investment arm of the government of Sweden.

The round was co-led by Pfizer Venture Investments and Novo Seeds, respective investment vehicles of pharmaceutical firms Pfizer and Novo.

Founded in 2010, Amra has developed a cloud-based platform that analyses data from a six-minute, whole-body MRI scan and translates it into precise fat and muscle measurements.

The company aims to help better understand how the relationship between fat and muscle affects metabolic risk, obesity and the development of conditions such as diabetes and cardiovascular disease.

The technology also has applications in clinical trials, as it is able to detect the efficiency of treatments.

Amra is based on research conducted at Linköping University’s Center for Medical Image Science and Visualization, Department of Biomedical Engineering and Department of Medicine and Health.

The funding will enable the company to expand into the US, through a new subsidiary. The company also aims to grow its network of pharmaceutical companies and researchers, as well as partner research institutions and hospitals.

Industrifonden previously invested SKr5m ($500,000) in Amra in 2014, before topping it up by an additional SKr10m a year later.

Søren Møller, managing partner at Novo Seeds, said: “One of the great health challenges globally is related to ageing and obesity, and there are over 2.1 billion individuals who are characterised as obese or overweight.

“Amra’s approach provides technology to identify different classes of obesity and thereby potentially reveal high metabolic risk profiles. Amra has the potential to play a vital role for research, clinical development and eventually patient management.”

– This article first appeared on our sister site Global University Venturing.

See more from this Government Report: Sweden

Back

Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.

Most read

  1. Big deal: British Business Bank launches $500m fund

    February 27, 2017

  2. Scohia Pharma to spin out of Takeda with $87m

    March 15, 2017

  3. Big deal: Airbnb takes series F booking from CIC

    March 13, 2017

  4. News round up 27 February 2017

    February 27, 2017

  5. Wills takes charge of Energy Technologies Institute

    March 07, 2017

Events

  • 23 May - 24 May, 2017

    GCV Symposium 2017 - London

    Join 400+ business leaders from the corporate venturing and wider high growth business ecosystem for the two-day 2017 GCV Symposium.

  • More Events